These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17032242)

  • 1. Regulatory activity of activated murine peripheral CD4+CD25- T cells: a possible mechanism of feedback regulation on adaptive immunity.
    Lu Y; Xu W; Zhou Y; Lv P; Gao XM
    Scand J Immunol; 2006 Nov; 64(5):500-6. PubMed ID: 17032242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppressive effect of induced CD4+CD25+ regulatory T cells from mice infected with Schistosoma japonicum].
    Tan MJ; Zhang YC; Wang Y; Hu W; Liang YJ; Zhang L
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):166-9, 173. PubMed ID: 19160959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells.
    Sato K; Tateishi S; Kubo K; Mimura T; Yamamoto K; Kanda H
    Biochem Biophys Res Commun; 2005 Apr; 330(1):226-32. PubMed ID: 15781254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
    Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ
    Transpl Immunol; 2008 Feb; 18(4):291-301. PubMed ID: 18158114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell.
    Chiffoleau E; Heslan JM; Heslan M; Louvet C; Condamine T; Cuturi MC
    Int Immunol; 2007 Feb; 19(2):193-201. PubMed ID: 17208927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD4(+)CD25(+) T regulatory cells in IL-2-induced vascular leak.
    Melencio L; McKallip RJ; Guan H; Ramakrishnan R; Jain R; Nagarkatti PS; Nagarkatti M
    Int Immunol; 2006 Oct; 18(10):1461-71. PubMed ID: 16914509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ CD25+ regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens.
    Eddahri F; Oldenhove G; Denanglaire S; Urbain J; Leo O; Andris F
    Eur J Immunol; 2006 Apr; 36(4):855-63. PubMed ID: 16511897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.